A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.
A plant species of the Salvia genus known as a spice and medicinal plant.
Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.
The characteristic three-dimensional shape of a molecule.
The parts of a macromolecule that directly participate in its specific combination with another molecule.

The carboxy terminus of the herpesvirus saimiri ORF 57 gene contains domains that are required for transactivation and transrepression. (1/699)

Herpesvirus saimiri (HVS) ORF 57 is homologous to genes identified in all classes of herpesviruses. We have previously shown that ORF 57 encodes a multifunctional protein, responsible for both transactivation and repression of viral gene expression at a post-transcriptional level. This suggests that the ORF 57 protein shares some functional similarities with the herpes simplex virus IE63/ICP27 and Epstein-Barr virus Mta proteins. However, little is known about the functional domains responsible for the properties of ORF 57 due to the limited homology shared between these proteins. In this report, we have identified the functional domains responsible for transactivation and repression by the ORF 57 protein. We demonstrate that the carboxy terminus is required for ORF 57 transactivation, repression and an intense SC-35 nuclear spotting. This region contains two highly conserved motifs amongst its homologues, a zinc finger-like motif and a highly hydrophobic domain. We further show that the hydrophobic domain is required for transactivation and is also involved in nuclear localization of the ORF 57 protein, whereas the zinc finger-like domain is required for transactivation, repression and the intense SC-35 nuclear spotting.  (+info)

Self-organizing neural network for modeling 3D QSAR of colchicinoids. (2/699)

A novel scheme for modeling 3D QSAR has been developed. A method involving multiple self-organizing neural network adjusted to be analyzed by the PLS (partial least squares) analysis was used to model 3D QSAR of the selected colchicinoids. The model obtained allows the identification of some structural determinants of the biological activity of compounds.  (+info)

MIPSIM: similarity analysis of molecular interaction potentials. (3/699)

SUMMARY: MIPSIM is a computational package designed to analyse and compare 3D distributions of molecular interaction potentials (MIP) of series of biomolecules.  (+info)

The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment. (4/699)

The UL34 gene of herpes simplex virus type 2 (HSV-2) is highly conserved in the herpesvirus family. The UL34 gene product was identified In lysates of HSV-2-infected cells as protein species with molecular masses of 31 and 32.5 kDa, the latter being a phosphorylated product. Synthesis of these proteins occurred at late times post-infection and was highly dependent on viral DNA synthesis. Immunofluorescence assays revealed that the UL34 protein was localized in the cytoplasm in a continuous net-like structure, closely resembling the staining pattern of the endoplasmic reticulum (ER), in both HSV-2-infected cells and in cells transiently expressing UL34 protein. Deletion mutant analysis showed that this colocalization required the C terminus of the UL34 protein. The UL34 protein associated with virions but not with A, B or C capsids. We treated virions, HSV-2-infected cells and cells expressing the UL34 protein with a protease in order to examine the topology of the UL34 protein. In addition, we constructed UL34 deletion mutant proteins and examined their intracellular localization. Our data strongly support the hypothesis that the UL34 protein is inserted into the viral envelope as a tail-anchored type II membrane protein and is significant for virus envelopment.  (+info)

Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. (5/699)

The antibody response to the envelope proteins of hepatitis C virus (HCV) may play an important role in controlling the infection. To allow molecular analyses of protective antibodies, we isolated human monoclonal antibodies to the E2 envelope glycoprotein of HCV from a combinatorial Fab library established from bone marrow of a chronically HCV-infected patient. Anti-E2 reactive clones were selected using recombinant E2 protein. The bone marrow donor carried HCV genotype 2b, and E2 used for selection was of genotype 1a. The antibody clones were expressed as Fab fragments in E. coli, and as Fab fragments and IgG1 in CHO cells. Seven different antibody clones were characterized, and shown to have high affinity for E2, genotype 1a. Three clones also had high affinity for E2 of genotype 1b. They all bind to conformation-dependent epitopes. Five clones compete for the same or overlapping binding sites, while two bind to one or two other epitopes of E2. Four clones corresponding to the different epitopes were tested as purified IgG1 for blocking the CD81-E2 interaction in vitro; all four were positive at 0.3-0.5 microg/ml. Thus, the present results suggest the existence of at least two conserved epitopes in E2 that mediate inhibition of the E2-CD81 interaction, of which one appeared immunodominant in this donor.  (+info)

Isolation of a Spodoptera exigua baculovirus recombinant with a 10.6 kbp genome deletion that retains biological activity. (6/699)

When Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV) is grown in insect cell culture, defective viruses are generated. These viruses lack about 25 kbp of sequence information and are no longer infectious for insects. This makes the engineering of SeMNPV for improved insecticidal activity or as expression vectors difficult to achieve. Recombinants of Autographa californica MNPV have been generated in insects after lipofection with viral DNA and a transfer vector into the haemocoel. In the present study a novel procedure to isolate SeMNPV recombinants was adopted by alternate cloning between insect larvae and cultured cells. The S. exigua cell line Se301 was used to select the putative recombinants by following a green fluorescent protein marker inserted in the p10 locus of SeMNPV. Polyhedra from individual plaques were fed to larvae to select for biological activity. In this way an SeMNPV recombinant (SeXD1) was obtained with the speed of kill improved by about 25%. This recombinant lacked 10593 bp of sequence information, located between 13.7 and 21.6 map units of SeMNPV and including ecdysteroid UDP glucosyl transferase, gp37, chitinase and cathepsin genes, as well as several genes unique to SeMNPV. The result indicated, however, that these genes are dispensable for virus replication both in vitro and in vivo. A mutant with a similar deletion was identified by PCR in the parental wild-type SeMNPV isolate, suggesting that genotypes with differential biological activities exist in field isolates of baculoviruses. The generation of recombinants in vivo, combined with the alternate cloning between insects and insect cells, is likely to be applicable to many baculovirus species in order to obtain biologically active recombinants.  (+info)

Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains. (7/699)

Prion replication involves conversion of the normal, host-encoded prion protein PrP(C), which is a sialoglycoprotein bound to the plasma membrane by a glycophosphatidylinositol anchor, into a pathogenic isoform, PrP(Sc). In earlier studies, tunicamycin prevented glycosylation of PrP(C) in scrapie-infected mouse neuroblastoma (ScN2a) cells but it was still expressed on the cell surface and converted into PrP(Sc); mutation of PrP(C) at glycosylation consensus sites (T182A, T198A) produced low steady-state levels of PrP that were insufficient to propagate prions in transgenic mice. By mutating asparagines to glutamines at the consensus sites, we obtained expression of unglycosylated, epitope-tagged MHM2PrP(N180Q,N196Q), which was converted into PrP(Sc) in ScN2a cells. Cultures of uninfected neuroblastoma (N2a) cells transiently expressing mutated PrP were exposed to brain homogenates prepared from mice infected with the RML, Me7 or 301V prion strains. In each case, mutated PrP was converted into PrP(Sc) as judged by Western blotting. These findings raise the possibility that the N2a cell line can support replication of different strains of prions.  (+info)

Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. (8/699)

The purpose of this study was to evaluate the feasibility of metabonomics technology for developing a rapid-throughput toxicity screen using 2 known hepatotoxicants: carbon tetrachloride (CCl(4)) and alpha-naphthylisothiocyanate (ANIT) and 2 known nephrotoxicants: 2-bromoethylamine (BEA) and 4-aminophenol (PAP). In addition, the diuretic furosemide (FURO) was also studied. Single doses of CCl(4) (0.1 and 0.5 ml/kg), ANIT (10 and 100 mg/kg), BEA (15 and 150 mg/kg), PAP (15 and 150 mg/kg) and FURO (1 and 5 mg) were administered as single IP or oral doses to groups of 4 male Wistar rats/dose. Twenty-four-h urine samples were collected pretest, daily through Day 4, and on Day 10 (high dose CCl(4) and BEA only). Blood samples were taken on Days 1, 2, and 4 or 1, 4, and 10 for clinical chemistry assessment, and the appropriate target organ was examined microscopically. NMR spectra of urine were acquired and the data processed and subjected to principal component analyses (PCA). The results demonstrated that the metabonomic approach could readily distinguish the onset and reversal of toxicity with good agreement between clinical chemistry and PCA data. In at least 2 instances (ANIT and BEA), PCA analysis suggested effects at low doses, which were not as evident by clinical chemistry or microscopic analysis. Furosemide, which had no effect at the doses employed, did not produce any changes in PCA patterns. These data support the contention that the metabonomic approach represents a promising new technology for the development of a rapid throughput in vivo toxicity screen.  (+info)

Quantitative Structure-Activity Relationship (QSAR) is a method used in toxicology and medicinal chemistry that attempts to establish mathematical relationships between the chemical structure of a compound and its biological activity. QSAR models are developed using statistical methods to analyze a set of compounds with known biological activities and their structural properties, which are represented as numerical or categorical descriptors. These models can then be used to predict the biological activity of new, structurally similar compounds.

QSAR models have been widely used in drug discovery and development, as well as in chemical risk assessment, to predict the potential toxicity of chemicals based on their structural properties. The accuracy and reliability of QSAR predictions depend on various factors, including the quality and diversity of the data used to develop the models, the choice of descriptors and statistical methods, and the applicability domain of the models.

In summary, QSAR is a quantitative method that uses mathematical relationships between chemical structure and biological activity to predict the potential toxicity or efficacy of new compounds based on their structural properties.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Molecular structure, in the context of biochemistry and molecular biology, refers to the arrangement and organization of atoms and chemical bonds within a molecule. It describes the three-dimensional layout of the constituent elements, including their spatial relationships, bond lengths, and angles. Understanding molecular structure is crucial for elucidating the functions and reactivities of biological macromolecules such as proteins, nucleic acids, lipids, and carbohydrates. Various experimental techniques, like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM), are employed to determine molecular structures at atomic resolution, providing valuable insights into their biological roles and potential therapeutic targets.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

Mescaline is a naturally occurring psychoactive alkaloid that is found in several species of cacti, including the peyote (Lophophora williamsii), San Pedro (Echinopsis pachanoi), and Peruvian torch (Echinopsis peruviana) cacti. It is known for its ability to produce profound changes in consciousness, mood, and perception when ingested.

In a medical context, mescaline is classified as a hallucinogen or psychedelic drug. It works by binding to serotonin receptors in the brain, which leads to altered states of consciousness, including visual hallucinations, distorted perceptions of time and space, and altered emotional states.

It's important to note that while mescaline has been used for centuries in religious and spiritual practices among indigenous communities, its use is not without risks. High doses can lead to unpleasant or even dangerous psychological effects, such as anxiety, panic, and psychosis. Additionally, the legal status of mescaline varies by country and region, so it's important to be aware of local laws and regulations before using it.

'Salvia officinalis', also known as garden sage or common sage, is not a medical condition but an herb that has been used in traditional medicine. Here's the botanical definition:

Salvia officinalis, commonly known as sage, garden sage, or common sage, is a perennial, evergreen subshrub, with woody stems, grayish leaves, and blue to purplish flowers. It belongs to the Lamiaceae family, also known as the mint family. The plant is native to the Mediterranean region and has been cultivated throughout the world for its aromatic leaves, which are used in cooking, cosmetics, and medicinal preparations.

In traditional medicine, sage leaves have been used to treat various conditions, such as sore throats, coughs, colds, and digestive issues. However, it is essential to note that the effectiveness of sage for these uses has not been thoroughly studied in clinical trials, and its use should not replace conventional medical care. Always consult with a healthcare professional before starting any new treatment or therapy.

A chemical model is a simplified representation or description of a chemical system, based on the laws of chemistry and physics. It is used to explain and predict the behavior of chemicals and chemical reactions. Chemical models can take many forms, including mathematical equations, diagrams, and computer simulations. They are often used in research, education, and industry to understand complex chemical processes and develop new products and technologies.

For example, a chemical model might be used to describe the way that atoms and molecules interact in a particular reaction, or to predict the properties of a new material. Chemical models can also be used to study the behavior of chemicals at the molecular level, such as how they bind to each other or how they are affected by changes in temperature or pressure.

It is important to note that chemical models are simplifications of reality and may not always accurately represent every aspect of a chemical system. They should be used with caution and validated against experimental data whenever possible.

"Drug design" is the process of creating and developing a new medication or therapeutic agent to treat or prevent a specific disease or condition. It involves identifying potential targets within the body, such as proteins or enzymes that are involved in the disease process, and then designing small molecules or biologics that can interact with these targets to produce a desired effect.

The drug design process typically involves several stages, including:

1. Target identification: Researchers identify a specific molecular target that is involved in the disease process.
2. Lead identification: Using computational methods and high-throughput screening techniques, researchers identify small molecules or biologics that can interact with the target.
3. Lead optimization: Researchers modify the chemical structure of the lead compound to improve its ability to interact with the target, as well as its safety and pharmacokinetic properties.
4. Preclinical testing: The optimized lead compound is tested in vitro (in a test tube or petri dish) and in vivo (in animals) to evaluate its safety and efficacy.
5. Clinical trials: If the preclinical testing is successful, the drug moves on to clinical trials in humans to further evaluate its safety and efficacy.

The ultimate goal of drug design is to create a new medication that is safe, effective, and can be used to improve the lives of patients with a specific disease or condition.

Molecular conformation, also known as spatial arrangement or configuration, refers to the specific three-dimensional shape and orientation of atoms that make up a molecule. It describes the precise manner in which bonds between atoms are arranged around a molecular framework, taking into account factors such as bond lengths, bond angles, and torsional angles.

Conformational isomers, or conformers, are different spatial arrangements of the same molecule that can interconvert without breaking chemical bonds. These isomers may have varying energies, stability, and reactivity, which can significantly impact a molecule's biological activity and function. Understanding molecular conformation is crucial in fields such as drug design, where small changes in conformation can lead to substantial differences in how a drug interacts with its target.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Some examples are quantitative structure-reactivity relationships (QSRRs), quantitative structure-chromatography relationships ... QSCRs) and, quantitative structure-toxicity relationships (QSTRs), quantitative structure-electrochemistry relationships (QSERs ... one can find a mathematical relationship, or quantitative structure-activity relationship, between the two. The mathematical ... While many quantitative structure activity relationship analyses involve the interactions of a family of molecules with an ...
Quantitative Structure-Activity Relationships. 18 (6): 548-560. CiteSeerX 10.1.1.669.1877. doi:10.1002/(SICI)1521-3838(199912) ... Gessner PK, Godse DD, Krull AH, McMullan JM (March 1968). "Structure-activity relationships among 5-methoxy-n:n- ...
"Atomic Physicochemical Parameters for Three-Dimensional Structure-Directed Quantitative Structure-Activity Relationships I. ... Scherrer RA, Howard SM (January 1977). "Use of distribution coefficients in quantitative structure-activity relationships". ... Quantitative Structure-Activity Relationships. 7 (3): 133-144. doi:10.1002/qsar.19880070304. Andrés A, Rosés M, Ràfols C, Bosch ... Kow, being a type of partition coefficient, serves as a measure of the relationship between lipophilicity (fat solubility) and ...
Part 1. QSAR analysis using molecular connectivity". Quantitative Structure-Activity Relationships. 17 (4): 327-337. doi: ... October 2021). "Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol" ( ... Totarol's anti-cancer activity is hypothesized to be due to the natural product's ability to form an o-quinone methide in vivo ... Lee MK, Yang H, Yoon JS, Jeong EJ, Kim DY, Ha NR, Sung SH, Kim YC (July 2008). "Antifibrotic activity of diterpenes from Biota ...
3.0.CO;2-U. So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: ... Quantitative Structure-Activity Relationships. 17 (1): 14-19. doi:10.1002/(SICI)1521-3838(199801)17:01. ...
Hadjipavlou-Litina D, Hansch C (1994). "Quantitative structure-activity relationships of the benzodiazepines. a review and ... So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and ... Quantitative Structure-Activity Relationships. 17 (1): 14-19. doi:10.1002/(SICI)1521-3838(199801)17:01. 3.0.CO;2-U. Thakur A, ... 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines. Chem Biol Drug ...
Bohl M, Simon Z, Vlad A, Kaufmann G, Ponsold K (1987). "MTD calculations on quantitative structure-activity relationships of ... The Case of Hard Molecules and Soft Receptors". Quantitative Structure-Activity Relationships. 11 (1): 23-28. doi:10.1002/qsar. ... Simon Z, Bohl M (1992). "Structure-activity Relations in Gestagenic Steroids by the MTD Method. ... It is about twice as potent as progesterone in terms of progestogenic activity in animal bioassays. 17α-BP is a parent compound ...
Quantitative Structure Activity Relationships (QSAR). Fragment based regression analysis for quantitative structure-activity ... Hansch may be best known as the father of the concept of quantitative structure-activity relationship (QSAR), the quantitative ... The Pioneer of QSAR". Quantitative Structure-Activity Relationships. 7 (3): 119-120. doi:10.1002/qsar.19880070302. Maugh, ... Hansch, Corwin (1993-04-01). "Quantitative structure-activity relationships and the unnamed science". Accounts of Chemical ...
Coburn RA, Solo AJ (June 1976). "Quantitative structure-activity relationships among steroids. Investigations of the use of ... Wolff ME (August 1974). "A quantitative reexamination of structure-activity relationships in the delta6-6-substituted ... Topliss JG, Shapiro EL (June 1975). "Quantitative structure-activity relationships in the delta6-6-substituted progesterone ... Shapiro EL, Weber L, Harris H, Miskowicz C, Neri R, Herzog HL (July 1972). "Synthesis and biological activity of 17-esters of 6 ...
Topliss, John (2012-12-02). Quantitative Structure-Activity Relationships of Drugs. Elsevier. p. 427. ISBN 9780323146876. Meyer ... 2-(1-methylpropyl)phenol takes up the nitronium ion to form the arenium ion, which has three resonance structures. Water can ... This compound had a superior contact and stomach activity on insects and mites. Dinoseb became commercially available in 1945 ... Saitoh, I., Miyoshi, H., Shimizu, R., and Iwamura, H. (1992). "Comparison of structure of quinone redox site in the ...
Analysis by quantitative structure-activity relationships. pp. 264-280. doi:10.1021/bk-1989-0413.ch018. ISBN 978-0-8412-1702-7 ... October 1974). "Structure-activity relationships in psychotomimetic phenylalkylamines". Journal of Medicinal Chemistry. 17 (10 ... "A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 ...
Liu Q, Hirono S, Moriguchi I (Aug 1990). "Quantitative structure-activity relationships for calmodulin inhibitors". Chemical & ... However, a recent effort to resolve the structure of human APRTase was unable to locate a single site for Mg2+, but did find ... Type I deficiency results in a complete loss of APRTase activity and can occur in patients that are homozygous or compound ... It is treatable with regular doses of allopurinol or febuxostat, which inhibit xanthine dehydrogenase activity to prevent the ...
... s found extensive application in quantitative structure-activity relationship (QSAR) studies for drug ... "Steric effects in quantitative structure-activity relationships". Pure and Applied Chemistry. 50 (9-10): 987-994. doi:10.1351/ ... Modeling Structure-Stereoselectivity Relationships with Steric and Electronic Parameters". Angewandte Chemie International ... These relationships describe the effects that ligand substituents have on reaction outcomes, namely enantioselectivity, and can ...
Quantitative structure-activity relationships (QSAR) or linear free energy relationships (LFER) such as the Hammett equation. A ... "Partitioning and lipophilicity in quantitative structure-activity relationships". Environmental Health Perspectives. 61: 203-28 ... Kow serves as a measure of the relationship between lipophilicity (fat solubility) and hydrophilicity (water solubility) of a ...
Quantitative structure activity relationship models (QSAR) for compounds; ■ Clinical trial drugs and their targets; ■ ... Structure-based activity landscape and drug-like property profile of targets; ■ Prodrugs together with their parent drug and ... structures and experimental activity values if available); ■ Differential expression profiles and downloadable data of targets ... Detailed knowledge about target function, sequence, 3D structure, ligand binding properties, enzyme nomenclature and drug ...
October 2010). "Quantitative structure-activity relationship studies of threo-methylphenidate analogs". Bioorganic & Medicinal ... 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs". Journal of Medicinal ... Singh S (March 2000). "Chemistry, design, and structure-activity relationship of cocaine antagonists". Chemical Reviews. 100 (3 ... its activity as a dopamine reuptake inhibitor. In theory, this would block some of the effects of cocaine, without being as ...
October 2010). "Quantitative structure-activity relationship studies of threo-methylphenidate analogs". Bioorganic & Medicinal ... 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs". Journal of Medicinal ...
Dixit N, Patel C, Bhavsar M, Patel S, Rawal R, Solanki H (2022-05-02). "Quantitative Structure-activity Relationship (QSAR) ...
In toxicology, the quantitative structure-activity relationship (QSAR) approach is a method for predicting toxicity based on ... For instance, FATS data is used to develop quantitative structure-activity relationship (QSAR) models. QSAR models developed ... Netzeva TI, Pavan M, Worth AP (January 2008). "Review of (Quantitative) Structure-Activity Relationships for Acute Aquatic ... Based on the QSAR approach, differences in the chemical structure can be used to predict the activity of toxicants. The ...
Nandihalli, Ujjana B.; Duke, Mary V.; Duke, Stephen O. (1992). "Quantitative structure-activity relationships of ... "Structure-Activity Relationships of Diphenyl Ethers and Other Oxygen-Bridged Protoporphyrinogen Oxidase Inhibitors". ...
Free-energy relationship Hammett equation Quantitative structure-activity relationship Eric Anslyn, E.; Dougherty, D. A. Modern ... This relationship can be visualized through a Hammett plot. However, if the solvent of the reaction is changed, but not the ... For many reactions and nucleophilic solvent systems, the relationships are not fully linear. This derives from the growing SN2 ... The Hammett equation (Equation 1) provides the relationship between the substituent on the benzene ring and the ionizing rate ...
... quantitative structure-activity relationships, and combinatorial chemistry. It was established in 1981 as Quantitative ... Structure-Activity Relationships and renamed to QSAR & Combinatorial Science in 2003, before obtaining its present name in 2010 ...
In the absence of such rate constants, quantitative structure-activity relationships(QSARs) may allow their estimation for a ... Canonica, S; Tratnyek, P. G. (2003). "Quantitative structure-activity relationships for oxidation reactions of organic ... Thus, although molecular structure generally predicts intrinsic reactivity, quantitative predictions are limited. ... A complimentary, potentially more quantitative technique is to directly enumerate the biodegradative gene(s) via quantitative ...
Free-energy relationship Hammett equation Quantitative structure-activity relationship Eric Anslyn, E.; Dougherty, D. A. Modern ... organic chemistry in the study of reaction mechanisms and in the development of quantitative structure-activity relationships ... employed in biological chemistry and medicinal chemistry for the development of quantitative structure-activity relationships ( ... 1988-08-01). "Radiation chemical production, lifetimes, and structure-activity relations for .alpha.-dialkoxyalkyl carbocations ...
2002). "Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and ... 1999). "Three dimensional-quantitative structure activity relationship analyses of substrates for CYP2B6". Pharm Exp Ther. 288 ... 2002). "Three dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein". Mol Pharmacol. 61 (5 ... Ekins, G. Wikel J.H.; Bravi, S.; Wrighton, SA (1999). "Three dimensional quantitative structure activity relationship (3D-QSAR ...
Gabriel, J. L.; Miller, T. F.; Wolfson, M. R. Jr; Shaffer, T. H. (1996). "Quantitative structure-activity relationships of ... PFC concentrations were generally higher in areas with more human population or industrial activity, and areas with more PFOS ... ISBN 978-0-13-033451-0. Danielson, Mark A.; Falke, Joseph J. (1996). "Use of 19F NMR to probe protein structure and ... Fluorine-19 is commonly used in NMR study of metabolism, protein structures and conformational changes. In addition, inert ...
"Quantitative Structure-Activity Relationships of Perfluorinated Hetero-Hydrocarbons as Potential Respiratory Media". ASAIO ... For further detail on α-fluorine, see the 1970 structure by Pauling. For further detail on the concept of disorder in crystals ... The latter crystallizes at −220 °C (−364 °F) and is transparent and soft, with the same disordered cubic structure of freshly ... ISBN 978-0-306-44610-8. Einstein, F. W. B.; Rao, P. R.; Trotter, J.; Bartlett, N. (1967). "The Crystal Structure of Gold ...
Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". ...
Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". ... January 2023). "In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of ...
Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". ...
Some examples are quantitative structure-reactivity relationships (QSRRs), quantitative structure-chromatography relationships ... QSCRs) and, quantitative structure-toxicity relationships (QSTRs), quantitative structure-electrochemistry relationships (QSERs ... one can find a mathematical relationship, or quantitative structure-activity relationship, between the two. The mathematical ... While many quantitative structure activity relationship analyses involve the interactions of a family of molecules with an ...
Three-dimensional quantitative structure-activity relationships (3D-QSAR) involve the analysis of the quantitative relationship ... Citation: three-dimensional quantitative structure-activity relationships in IUPAC Compendium of Chemical Terminology, 3rd ed ... between the biological activity of a set of compounds and their three-dimensional properties using statistical correlation ...
Research interests include computer-aided drug design, structure-activity modeling, drug reprofiling, new therapies and ... As a result, new thiazole derivatives with the potential anti-inflammatory activity were designed and their activity has been ... He started as PostDoc in Structure-Based Drug Design (SBDD) modeling HIV virus mutations to Xray structures for translating ... The scientific activity of Prof. Cruciani is documented by more than 150 papers. In 2001 he got the Corvin Hansch Award from ...
... quantitative structure-activity relationships. e-Archivo Repository. Versión en español , Login ... Biocatalytic oxidation of phenolic compounds by bovine methemoglobin in the presence of H2O2: quantitative structure-activity ... and good correlation between peroxidase-like and catalase-like activities of the protein was observed. It is also shown that ... which describes the intrinsic redox activity of the substrates and the pKa-values, which are related to substrate ionization. ...
Title: Quantitative Structure Activity Relationship Studies of Sulfamide Derivatives as Carbonic Anhydrase Inhibitor: As ... Quantitative Structure Activity Relationship Studies of Sulfamide Derivatives as Carbonic Anhydrase Inhibitor: As Antiglaucoma ... In this paper we have represented "Three Dimensional Quantitative Structure Activity Relationship" study to characterize ... In this paper we have represented "Three Dimensional Quantitative Structure Activity Relationship" study to characterize ...
The TMACC interpretation can provide new insight into the structure-activity relationships studied. Freely available, open ... Blue circles surround atoms which were studied for activity. Methoxy groups located at all positions of the benzyl ring were ...
... molecules physiological activity in order to construct a model that links the chemical structure to the physiological activity ... Quantitative Structure Activity Relationship (QSAR) The 2D-QSAR technique is a drug design approach that utilizes the ... The structure data utilised in the standard two-dimensional quantitative structure-activity relationship can only represent the ... By enhancing the structural parameters, the 2D structures effectively dictates 2D QSAR (Qualitative Structure Activity ...
... Share "Unbalance Quantitative Structure ... Quantitative structure-activity relationship (QSAR) has been used to study the relationships between the antifungal activity ... Abstract: Problem statement: Activities of drug molecules can be predicted by Quantitative Structure Activity Relationship ( ... Quantitative structure-activity relationship of some 1-benzylbenzimidazole derivatives as antifungal agents 9 ...
QSAR (Quantitative Structure Activity Relationship). European Chemicals Bureau: Computational Toxicology. Risk assessment. ...
Voltar aos Detalhes do Artigo QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSAR) STUDY ON NOVEL 4-AMIDINOQUINOLINE AND 10- ...
Analysis of a Quantitative Relationship Between the Structure and Analgesic Activity of Meperidin Derivatives Using Semi- ...
Molecular docking and quantitative structure-activity relationship study of anticonvulsant activity of aminobenzothiazole ... A quantitative structure-activity relationship and molecular docking studies have been made on 30 benzo[d]thiazole series as H+ ... MOLECULAR DOCKING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) STUDIES OF SOME SELECTED ANTI-ULCER INHIBITORS ... Aliyu Wappah Mahmud, Gideon Adamu Shallangwa, Adamu Uzairu, QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSAR) STUDY ON NOVEL ...
Quantitative Structure-Activity Relationship (Qsar) Market 2020 - Understanding The Competitive Landscape. * Posted byby Nix ... According to our new market research study on "Quantitative Structure-Activity Relationship (QSAR) Market Forecast to 2027 - ... Quantitative Structure-Activity Relationship (Qsar) Market Size. 1 Posts. Tag: Quantitative Structure-Activity Relationship ( ...
4D- quantitative structure-activity relationship modeling: making a comeback. 4D- quantitative structure-activity relationship ... Predictive Quantitative Structure-Activity Relationship (QSAR) modeling has become an essential methodology for rapidly ... and/or three-dimensional structures of molecules. However, the conformation-dependent characteristics of flexible molecules and ...
ARTIGO_Quantitative structure-activity relationship studies for potential rho-associated protein kinase .pdf. 1,87 MB. Adobe ... Quantitative structure-activity relationship studies for potential rho-associated protein kinase inhibitors. Journal of ... Quantitative structure-activity relationship studies for potential rho-associated protein kinase inhibitors. ... as Rho-associated protein kinase inhibitors were subjected to four-dimensional quantitative structure-activity relationship (4D ...
Bisphenol analogues inhibit human and rat 17ß-hydroxysteroid dehydrogenase 1: 3D-quantitative structure-activity relationship ( ... quantitative structure-activity relationship (3D-QSAR) and mode of action. We observed some bisphenols with substituents were ... and hydrogen bond acceptor are key factors for the inhibition of steroid synthesis activity of 17ß-HSD1. ...
OECD (Quantitative) Structure-Activity Relationships. QA. Quality Assurance. QWIDS. Query Wizard for International Development ...
... analysis is a practical approach by which chemical structure is quantitatively correlated with biologi ... Abstract: Quantitative structure-activity relationship (QSAR) analysis is a practical approach by which chemical structure is ... Quantitative structure-activity relationship (QSAR) analysis is a practical approach by which chemical structure is ... Quantitative Structure-Activity Relationship (QSAR) Analysis to Predict Drug-Drug Interactions of ABC Transporter ABCG2. Author ...
Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells : description of quantitative structure-activity relationships. ... Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells : description of quantitative structure-activity relationships ... Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells : description of quantitative structure-activity relationships ... description of quantitative structure-activity relationships. FEBS Letters. 1999;462:392-396. doi: 10.1016/S0014-5793(99)01561- ...
Quantitative Structure-Activity Relationship * Solutions Substances * Ligands * Multienzyme Complexes * Solutions * Guanosine ... As reported here, the solution structure has a mixed α/β fold consisting of seven β-strands and five α-helices, which is very ... The failure of repeated attempts to crystallize ligand-free (apo) CobY prompted us to explore its 3D structure by solution NMR ...
Kim, J. S., Sun, Q., Yu, C., Liu, A., Liu, L. F., & Lavoie, E. J. (1998). Quantitative structure-activity relationships on 5- ... Kim, JS, Sun, Q, Yu, C, Liu, A, Liu, LF & Lavoie, EJ 1998, Quantitative structure-activity relationships on 5-substituted ... T1 - Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor ... Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor ...
Exploring Quantitative Structure-Activity Relationships (QSARs) of Cyclooxygenase-2 (COX-2) Inhibitors by MLR, PLS and PC-ANN ...
These models reveal the general interactions that impart asymmetric induction and allow the quantitative transfer of this ... Application of quantitative structure activity/selectivity relationships. J. Org. Chem. 76, 4337-4357 (2011). ... Reid, J. P. & Sigman, M. S. Comparing quantitative prediction methods for the discovery of small-molecule chiral catalysts. Nat ... These models reveal the general interactions that impart asymmetric induction and allow the quantitative transfer of this ...
A series of 172 molecular structures that block the hERG K+ channel were used to develop a classification model where, ... Mansouri K, Ringsted T, Ballabio D, Todeschini R, Consonni V (2013) Quantitative structure-activity relationship models for ... through to more complex quantitative structure-activity relationship (QSAR) models [12-16]. A number of QSAR models have been ... molecular insights from structure-activity relationships of clofilium and ibutilide analogs. Mol Pharmacol 69(2):509-519 ...
Quantitative Structure Activity Relationship Studies of Some New 4-Thiazolidinone Derivatives as Antimicrobial Agents ... Quantitative Structure Activity Relationship Studies of Some New 4-Thiazolidinone Derivatives as Antimicrobial Agents. Research ... Quantitative Structure Activity Relationship Studies of Some New 4-Thiazolidinone Derivatives as Antimicrobial Agents. ... In the present study, quantitative structure activity relationship (QSAR) studies have been performed on series of 24 compounds ...
Out of more than hundred plant flavonoids, ten flavonoid structures are presented in this study. On the basis of best docking ... The value of correlation coefficient (r) 0.95 shows that there was a good correlation between flavonoid structures and selected ... These flavonoids can directly work as anti-dengue drug or with little modifications in their structures. ... Studies about structure activity relationship (SAR) and quantitative structure activity relationship (QSAR). The Structure- ...
Development of quantitative structure-activity relationships for explanatory modeling of fast reacting (meth)acrylate monomers ...
Quantitative Structure-Activity Relationship. References. *Sriram, K.; Insel, P.A. G Protein-Coupled Receptors as Targets for ... of analogue compounds will provide data for ligand-based analysis to determine a quantitative structure-activity relationship ( ... Tautermann, C.S. GPCR structures in drug design, emerging opportunities with new structures. Bioorg. Med. Chem. Lett. 2014, 24 ... Despite the great progress in GPCR structure determination, no experimental structure of a csGPCR is currently available and 3D ...
3D quantitative structure activity relationships with CoRSA. Comparative receptor surface analysis. Application to calcium ... Free and Open Source Chemistry Software in Research of Quantitative Structure-Toxicity Relationship of Pesticides MATEC Web of ... The top 20 variables that have the greatest influence on biological activity ...

No FAQ available that match "quantitative structure activity relationship"